Koshkina N - Search Results

1

Gold nanoparticles stabilized with MPEG-grafted poly(l-lysine): in vitro and in vivo evaluation of a potential theranostic agent.

Bogdanov AA Jr, Gupta S, Koshkina N, Corr SJ, Zhang S, Curley SA, Han G. Bogdanov AA Jr, et al. Among authors: koshkina n. Bioconjug Chem. 2015 Jan 21;26(1):39-50. doi: 10.1021/bc5005087. Epub 2014 Dec 11. Bioconjug Chem. 2015. PMID: 25496453 Free PMC article.

2

Tumor selective hyperthermia induced by short-wave capacitively-coupled RF electric-fields.

Raoof M, Cisneros BT, Corr SJ, Palalon F, Curley SA, Koshkina NV. Raoof M, et al. PLoS One. 2013 Jul 4;8(7):e68506. doi: 10.1371/journal.pone.0068506. Print 2013. PLoS One. 2013. PMID: 23861912 Free PMC article.

3

Autophagy and enhanced chemosensitivity in experimental pancreatic cancers induced by noninvasive radiofrequency field treatment.

Koshkina NV, Briggs K, Palalon F, Curley SA. Koshkina NV, et al. Cancer. 2014 Feb 15;120(4):480-91. doi: 10.1002/cncr.28453. Epub 2013 Oct 25. Cancer. 2014. PMID: 24496866 Free PMC article.

4

The effects of non-invasive radiofrequency treatment and hyperthermia on malignant and nonmalignant cells.

Curley SA, Palalon F, Sanders KE, Koshkina NV. Curley SA, et al. Among authors: koshkina nv. Int J Environ Res Public Health. 2014 Sep 3;11(9):9142-53. doi: 10.3390/ijerph110909142. Int J Environ Res Public Health. 2014. PMID: 25192147 Free PMC article.

5

Radiofrequency treatment alters cancer cell phenotype.

Ware MJ, Tinger S, Colbert KL, Corr SJ, Rees P, Koshkina N, Curley S, Summers HD, Godin B. Ware MJ, et al. Among authors: koshkina n. Sci Rep. 2015 Jul 13;5:12083. doi: 10.1038/srep12083. Sci Rep. 2015. PMID: 26165830 Free PMC article.

6

Noninvasive radiofrequency treatment effect on mitochondria in pancreatic cancer cells.

Curley SA, Palalon F, Lu X, Koshkina NV. Curley SA, et al. Among authors: koshkina nv. Cancer. 2014 Nov 1;120(21):3418-25. doi: 10.1002/cncr.28895. Epub 2014 Jul 1. Cancer. 2014. PMID: 24986120 Free PMC article.

7

Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases.

Koshkina NV, Kleinerman ES. Koshkina NV, et al. Int J Cancer. 2005 Sep 1;116(3):458-63. doi: 10.1002/ijc.21011. Int J Cancer. 2005. PMID: 15800950 Free article.

8

Effect of the histone deacetylase inhibitor SNDX-275 on Fas signaling in osteosarcoma cells and the feasibility of its topical application for the treatment of osteosarcoma lung metastases.

Koshkina NV, Rao-Bindal K, Kleinerman ES. Koshkina NV, et al. Cancer. 2011 Aug 1;117(15):3457-67. doi: 10.1002/cncr.25884. Epub 2011 Feb 1. Cancer. 2011. PMID: 21287529 Free PMC article.

9

Expression of granulocyte-colony-stimulating factor and its receptor in human Ewing sarcoma cells and patient tumor specimens: potential consequences of granulocyte-colony-stimulating factor administration.

Morales-Arias J, Meyers PA, Bolontrade MF, Rodriguez N, Zhou Z, Reddy K, Chou AJ, Koshkina NV, Kleinerman ES. Morales-Arias J, et al. Among authors: koshkina nv. Cancer. 2007 Oct 1;110(7):1568-77. doi: 10.1002/cncr.22964. Cancer. 2007. PMID: 17694551 Free article.

10

Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases.

Duan X, Jia SF, Koshkina N, Kleinerman ES. Duan X, et al. Among authors: koshkina n. Cancer. 2006 Mar 15;106(6):1382-8. doi: 10.1002/cncr.21744. Cancer. 2006. PMID: 16453328 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page